The multiple ways climate change threatens to make migraines worse
September 20, 2024

The University of Cincinnati's Vince Martin, MD, was featured in a Wired article discussing how climate change could worsen migraines.
September 20, 2024
The University of Cincinnati's Vince Martin, MD, was featured in a Wired article discussing how climate change could worsen migraines.
September 25, 2024
The University of Cincinnati's Vincent Martin told Medscape that every primary care clinician should know about monoclonal antibodies for preventing migraines that are changing the lives of patients.
September 9, 2024
The University of Cincinnati's Mahmoud Charif was featured in an Everyday Health article discussing treatment options when metastatic triple-negative breast cancer becomes unresponsive to chemotherapy.
January 31, 2025
The University of Cincinnati Cancer Center's Davendra Sohal was featured in a New York Times article where oncologists answered seven big questions surrounding cancer today.
November 25, 2024
A growing body of evidence suggests those in the low- and middle-income brackets are more likely to develop long COVID-19, to suffer longer with its symptoms and to endure job loss, eviction and other serious consequences because of it.
April 23, 2025
Experts say women who have migraine symptoms linked to their menstrual cycle are prone to migraine problems during perimenopause.
May 5, 2025
A rapidly growing heart failure epidemic calls for prioritizing primary prevention, according to a new scientific statement from the American Heart Association published in Circulation in April. The statement reviews the current evidence for predicting heart failure risk and offers risk-based strategies for heart failure prevention.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.